Literature DB >> 31873739

Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply.

Iris Navarro-Millán1,2, Parag Goyal1, Monika M Safford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31873739      PMCID： PMC8204885          DOI： 10.1093/rheumatology/kez489

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.

Authors:  Iris Navarro-Millán; Parag Goyal; Monika M Safford
Journal:  Rheumatology (Oxford)       Date:  2019-06-01       Impact factor: 7.580

2.  The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.

Authors:  Elena Myasoedova; Arun Chandran; Birkan Ilhan; Brittny T Major; C John Michet; Eric L Matteson; Cynthia S Crowson
Journal:  Ann Rheum Dis       Date:  2015-01-30       Impact factor: 19.103

3.  Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.

Authors:  Mark Garton; Iain B McInnes; Naveed Sattar
Journal:  Rheumatology (Oxford)       Date:  2020-02-01       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.